BRGTM - Technical Information

  • Using Bio Regenerate’s proprietary method, the BRGTM cells are recovered from 450ml of un-mobilized peripheral blood.
  • The method recovers 25-85x106 stem/progenitor cells.
  • The cells in the recovered population express surface markers of hematopoietic, mesenchymal, endothelial and monocytic origin.
  • The BRGTM cells can differentiate into endothelial and hematopoietic progenitor cells and express some characteristics of mesenchymal stem cells.
  • In Vivo activity: The BRGTM cells were demonstrated to improve blood flow regeneration in a mouse limb ischemia model.